Episurf Medical provides COVID-19 related trading update
Episurf Medical (Nasdaq: EPIS B) today provides updates regarding business activity during the first nine months of 2021, reflecting impacts from the current pandemic. The company concludes that EBT and cash position for the third quarter 2021 are in line with expectation, while there have been COVID-19 related impacts on net sales and gross order intake. “This year, it was evident to us that potential patients and surgeons used the summer months for vacation and traveling, as those activities had been put on hold for a long time. People were also uncertain about COVID-19 related